Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital health program aims to ease menopause symptoms and cut heart risk in women with abdominal obesity

NCT ID NCT07713862

Disease control Sponsor: National University Health System, Singapore Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests whether a personalized digital health program — using a smartphone app, wearable devices, and lifestyle coaching — can help midlife women with abdominal obesity improve their diet, physical activity, sleep, and menopausal symptoms. Participants will wear a smartwatch, log food and symptoms in an app, and receive tailored recommendations. The goal is to see if this approach can reduce belly fat and improve heart health during the menopause transition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a personalized digital health program using a smartphone app, wearable devices, and lifestyle coaching
What this could lead to
If successful, this approach could offer a non-drug way to help midlife women manage menopausal symptoms and reduce heart disease risk.
What could go wrong
This is an early observational study without a control group, so it cannot prove cause and effect. Results may not apply to women not using smartphones or wearables.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 21-65 years old; * Report at least mild climacteric symptoms as indicated by an MRS score ≥5; * Waist circumference ≥80 cm, indicating abdominal adiposity; * Own and use a smartphone compatible with the CGM and Oura Ring. Exclusion Criteria: * Are currently receiving hormone replacement therapy (HRT); * Are currently using oral contraceptives; * Have been diagnosed with severe psychiatric illness requiring inpatient care; * Are concurrently enrolled in another behavioural or psychotherapy trial; * Have significant cognitive impairment or inability to engage with digital tools; * Have uncontrolled chronic medical conditions that may interfere with study participation; * Unable to comprehend written and spoken English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopause are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Menopause

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.